NYMOX PHARMACEUTICAL SAYS SAFETY COMMITTEE REVIEW ON PHASE 2 TRIAL OF NX-1207 REVEALS NO SERIOUS SIDE EFFECTS

Recommended Products

EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements

The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.

Accelerating-generic-drug-development-130x160

Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition

Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.

Events

View All

Feb 19

Medical Device Risk Management: Prepare for the Winds of Change

Feb 20

FDA’s Plan for Modernizing the 510(k) Pathway: What Regulatory, Quality & Compliance Professionals…

Feb 27

FDA Medical Device Compliance and Enforcement: Lessons from Last Year and Your Game Plan…

Mar 20

Medical Device Complaint Management: Escape the Labyrinth

Mar 22

REMS Regulatory Developments and Best Practices

Mar 26

Conducting Advanced Root Cause Analysis and CAPA Investigations

Editor's Picks

View all

BSI Warns Devicemakers to Migrate CE Certificates Before Brexit Deadline

BSI said that when it initiated its contingency plan in August 2016, it “could not have foreseen the lack of political progress” toward a Brexit resolution.

Democrats Introduce Price Gouging Bill

Brown and Gillibrand said the money from fines would be used for drug research and development.